Global Melanoma Market and Competitive Landscape – 2017

Lowest Prices Guaranteed	Publisher	Published Date	SKU
from $3,990	Fore Pharma	August, 2017	FPCI15450525

Lowest Prices Guaranteed
Price	from $3,990
Publisher	Fore Pharma
Published Date	August, 2017
SKU	FPCI15450525

PDF E-mail From Publisher:	$3,990
Global Site License Fulfilled by Publisher:	$5,650

Research assistance

US: 800.298.5699

Int'l: +1.240.747.3093

Table of Contents
Description

Global Melanoma Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Melanoma Market and Competitive Landscape – 2017, provides comprehensive insights into Melanoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Melanoma market size and drug sales. This research also provides insights into Melanoma epidemiology and late stage pipeline.
The report is classified into twelve sections – Melanoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Melanoma pipeline insights covering late stage clinical trials pipeline; Melanoma prevalence trends by countries; Melanoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

Melanoma pipeline: Find out the drugs in clinical trials for Melanoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
Melanoma epidemiology: Find out the prevalence of Melanoma by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
Melanoma products: Identify key products marketed and prescribed for Melanoma by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Melanoma market size: Find out the market size for Melanoma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
Melanoma drug sales: Find out the sales of Melanoma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
Melanoma drugs sales forecast: Sales forecast for Melanoma drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Melanoma market share analysis: Find out the market shares of Melanoma drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

Evaluate commercial market opportunities for Melanoma drugs
Synthesize insights for business development & licensing
Track market size, competitor drug sales, market shares in Melanoma market
Develop in-depth knowledge of competition and markets
Analyze sales data to update your brand planning trackers
Develop tactics and strategies to take advantage of opportunities in the market
Track market trends and analyze key events in Melanoma market
Develop forecast models, healthcare frameworks, or economic models
Answer key business questions; supports decision making in R&D to long term marketing strategies

1. Melanoma: Disease Overview: 1.1. Melanoma Symptoms; 1.2. Melanoma Etiology; 1.3. Melanoma Diagnosis; 1.4. Melanoma Treatment Options
2. Melanoma Pipeline Insights: 2.1. Melanoma Phase 3 Clinical Trials; 2.2. Melanoma Phase 2 Clinical Trials; 2.3. Melanoma Phase 1 Clinical Trials
3. Melanoma Epidemiology Analysis
4. US Melanoma Market Insights: 4.1. Marketed Products for Melanoma in US; 4.2. US Melanoma Market Size & Forecast; 4.3. US Melanoma Product Sales Forecast; 4.4. US Melanoma Market Share Analysis
5. Germany Melanoma Market Insights: 5.1. Marketed Products for Melanoma in Germany; 5.2. Germany Melanoma Market Size & Forecast; 5.3. Germany Melanoma Product Sales Forecast; 5.4. Germany Melanoma Market Share Analysis
6. France Melanoma Market Insights: 6.1. Marketed Products for Melanoma in France; 6.2. France Melanoma Market Size & Forecast; 6.3. France Melanoma Product Sales Forecast; 6.4. France Melanoma Market Share Analysis
7. Italy Melanoma Market Insights: 7.1. Marketed Products for Melanoma in Italy; 7.2. Italy Melanoma Market Size & Forecast; 7.3. Italy Melanoma Product Sales Forecast; 7.4. Italy Melanoma Market Share Analysis
8. Spain Melanoma Market Insights: 8.1. Marketed Products for Melanoma in Spain; 8.2. Spain Melanoma Market Size & Forecast; 8.3. Spain Melanoma Product Sales Forecast; 8.4. Spain Melanoma Market Share Analysis
9. UK Melanoma Market Insights: 9.1. Marketed Products for Melanoma in UK; 9.2. UK Melanoma Market Size & Forecast; 9.3. UK Melanoma Product Sales Forecast; 9.4. UK Melanoma Market Share Analysis
10. Europe Melanoma Market Insights: 10.1. Europe Melanoma Market Size & Forecast; 10.2. Europe Melanoma Product Sales Forecast; 10.3. Europe Melanoma Market Share Analysis
11. Japan Melanoma Market Insights: 11.1. Marketed Products for Melanoma in Japan; 11.2. Japan Melanoma Market Size & Forecast; 11.3. Japan Melanoma Product Sales Forecast; 11.4. Japan Melanoma Market Share Analysis
12. Global Melanoma Market Insights: 12.1. Global Melanoma Market Size & Forecast; 12.2. Global Melanoma Product Sales Forecast; 12.3. Global Melanoma Market Share Analysis
13. Research Methodology
LIST OF TABLES: Table 1: Melanoma Phase 3 Clinical Trials, Global, 2017; Table 2: Melanoma Phase 2 Clinical Trials, Global, 2017; Table 3: Melanoma Phase 1 Clinical Trials, Global, 2017; Table 4: Melanoma Prevalence by G7 Countries, 2012 - 2021; Table 5: Marketed Products for Melanoma in US, 2017; Table 6: US Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 7: US Melanoma Product Sales ($mn), 2012 - 2021; Table 8: US Melanoma Market Trends, 2012 - 2021; Table 9: Marketed Products for Melanoma in Germany, 2017; Table 10: Germany Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 11: Germany Melanoma Product Sales ($mn), 2012 - 2021; Table 12: Germany Melanoma Market Trends, 2012 - 2021; Table 13: Marketed Products for Melanoma in France, 2017; Table 14: France Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 15: France Melanoma Product Sales ($mn), 2012 - 2021; Table 16: France Melanoma Market Trends, 2012 - 2021; Table 17: Marketed Products for Melanoma in Italy, 2017; Table 18: Italy Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 19: Italy Melanoma Product Sales ($mn), 2012 - 2021; Table 20: Italy Melanoma Market Trends, 2012 - 2021; Table 21: Marketed Products for Melanoma in Spain, 2017; Table 22: Spain Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 23: Spain Melanoma Product Sales ($mn), 2012 - 2021; Table 24: Spain Melanoma Market Trends, 2012 - 2021; Table 25: Marketed Products for Melanoma in UK, 2017; Table 26: UK Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 27: UK Melanoma Product Sales ($mn), 2012 - 2021; Table 28: UK Melanoma Market Trends, 2012 - 2021; Table 29: Europe Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 30: Europe Melanoma Product Sales ($mn), 2012 - 2021; Table 31: Marketed Products for Melanoma in Japan, 2017; Table 32: Japan Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 33: Japan Melanoma Product Sales ($mn), 2012 - 2021; Table 34: Japan Melanoma Market Trends, 2012 - 2021; Table 35: Global Melanoma Market Size & Forecast ($mn), 2012 - 2021; Table 36: Global Melanoma Product Sales ($mn), 2012 - 2021
LIST OF FIGURES: Figure 1: Melanoma Pipeline by Phase (%), Global, 2017; Figure 2: Melanoma Prevalence by G7 Countries, 2012 - 2021; Figure 3: US Melanoma Market Size ($mn), 2012 - 2021; Figure 4: US Melanoma Product Sales ($mn), 2012 - 2021; Figure 5: US Melanoma Market Share by Products (%), 2016; Figure 6: US Melanoma Market - Future Market Share (%), 2021; Figure 7: Germany Melanoma Market Size ($mn), 2012 - 2021; Figure 8: Germany Melanoma Product Sales ($mn), 2012 - 2021; Figure 9: Germany Melanoma Market Share by Products (%), 2016; Figure 10: Germany Melanoma Market - Future Market Share (%), 2021; Figure 11: France Melanoma Market Size ($mn), 2012 - 2021; Figure 12: France Melanoma Product Sales ($mn), 2012 - 2021; Figure 13: France Melanoma Market Share by Products (%), 2016; Figure 14: France Melanoma Market - Future Market Share (%), 2021; Figure 15: Italy Melanoma Market Size ($mn), 2012 - 2021; Figure 16: Italy Melanoma Product Sales ($mn), 2012 - 2021; Figure 17: Italy Melanoma Market Share by Products (%), 2016; Figure 18: Italy Melanoma Market - Future Market Share (%), 2021; Figure 19: Spain Melanoma Market Size ($mn), 2012 - 2021; Figure 20: Spain Melanoma Product Sales ($mn), 2012 - 2021; Figure 21: Spain Melanoma Market Share by Products (%), 2016; Figure 22: Spain Melanoma Market - Future Market Share (%), 2021; Figure 23: UK Melanoma Market Size ($mn), 2012 - 2021; Figure 24: UK Melanoma Product Sales ($mn), 2012 - 2021; Figure 25: UK Melanoma Market Share by Products (%), 2016; Figure 26: UK Melanoma Market - Future Market Share (%), 2021; Figure 27: Europe Melanoma Market Size ($mn), 2012 - 2021; Figure 28: Europe Melanoma Product Sales ($mn), 2012 - 2021; Figure 29: Europe Melanoma Market Share by Products (%), 2016; Figure 30: Europe Melanoma Market - Future Market Share (%), 2021; Figure 31: Japan Melanoma Market Size ($mn), 2012 - 2021; Figure 32: Japan Melanoma Product Sales ($mn), 2012 - 2021; Figure 33: Japan Melanoma Market Share by Products (%), 2016; Figure 34: Japan Melanoma Market - Future Market Share (%), 2021; Figure 35: Global Melanoma Market Size ($mn), 2012 - 2021; Figure 36: Global Melanoma Product Sales ($mn), 2012 - 2021; Figure 37: Global Melanoma Market Share by Products (%), 2016; Figure 38: Global Melanoma Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Global Melanoma Market and Competitive Landscape – 2017

Share this report

Other tasks